Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

CME Group Inc. Reports Third-Quarter 2014 Financial Results

Date 30/10/2014

CME Group Inc. (NASDAQ: CME) today reported revenues of $762 million and operating income of $430 million for the third quarter of 2014.  Net income attributable to CME Group was $290 million and diluted earnings per share were $0.86. Excluding the items noted in the reconciliation, adjusted earnings per share would have been $0.84[1].

"Our core business performed very well during the third quarter, with our record overall options volume and record volume from outside the United States accounting for 60 percent of the quarterly volume growth," said CME Group Executive Chairman and President Terry Duffy.  "In addition, the momentum has continued, and October is on track to have the highest monthly volume in our history.  In particular, on October 15 we set an all-time daily record with volume approaching 40 million contracts.  This reflects the significant client demand during a more volatile period, supported by the company's unmatched liquidity, tight bid-ask spreads, system reliability and capital efficiency.  Bottom line, with nearly 9 million contracts traded that day from Europe, Asia and Latin America, we truly are the place where the world comes to manage risk."

"During the third quarter, we streamlined our organizational structure to better meet the needs of our global client base and accelerate future earnings growth and cash flow," said CME Group Chief Executive Officer Phupinder Gill.  "With increased agility from an operational perspective, we are aggressively focused on improving execution, enhancing efficiency and increasing our speed to market throughout the world.  If we are successful, revenues will increase and expenses decrease, and our shareholders will be rewarded as we further strengthen our position in the evolving global marketplace.  Based on our current plans, we expect to keep operating expenses essentially flat in 2015 relative to this year."

Third-quarter 2014 average daily volume was 13.5 million contracts, up 12 percent from third-quarter 2013.  Clearing and transaction fee revenues were $641.8 million, up 7 percent compared with third-quarter 2013.  Third-quarter 2014 total average rate per contract was 72.5 cents, down from 74.9 cents in second-quarter 2014, driven primarily by the 7 percent growth in total volume made up of a higher proportion of lower priced financial products.

As of September 30, 2014, the company had $1.2 billion of cash and marketable securities and $2.1 billion of long-term debt.

Guidance

CME Group full-year 2014 adjusted operating expenses are expected to be approximately $1.3 billion, at the low-end of the previously stated range.  Based upon the impact related to the recent reorganization and other expense management initiatives, the company's current estimate of 2015 operating expenses is the same as 2014, at approximately $1.3 billion.  The estimate excludes the impact of the pending transaction with GFI Group.

CME Group will hold a conference call to discuss third-quarter 2014 results at 8:30 a.m. Eastern Time today. A live audio Webcast of the call will be available on the Investor Relations section of CME Group's Web site at www.cmegroup.com. An archived recording will be available for up to two months after the call.

1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to Non-GAAP Measures chart at the end of the financial statements.

CME Group Inc. and Subsidiaries

Consolidated Balance Sheets

(in millions)




September 30, 2014


December 31, 2013

ASSETS





Current Assets:





Cash and cash equivalents


$

1,087.9


$

2,469.7

Marketable securities


72.8


68.4

Accounts receivable, net of allowance


344.8


302.7

Other current assets (includes $37.0 and $40.0 in restricted cash)


275.6


209.7

Performance bonds and guaranty fund contributions


32,385.3


21,355.1

Total current assets


34,166.4


24,405.6

Property, net of accumulated depreciation and amortization


498.7


513.4

Intangible assets—trading products


17,175.3


17,175.3

Intangible assets—other, net


2,662.3


2,741.2

Goodwill


7,569.0


7,569.0

Other assets (includes $74.7 and $74.0 in restricted cash)


1,898.6


1,873.3

Total Assets


$

63,970.3


$

54,277.8

LIABILITIES AND EQUITY





Current Liabilities:





Accounts payable


$

35.0


$

36.2

Short-term debt



749.9

Other current liabilities


207.6


1,169.8

Performance bonds and guaranty fund contributions


32,385.3


21,355.1

Total current liabilities


32,627.9


23,311.0

Long-term debt


2,107.7


2,107.2

Deferred income tax liabilities, net


7,308.4


7,249.7

Other liabilities


389.2


449.4

Total Liabilities


42,433.2


33,117.3

CME Group shareholders' equity


21,537.1


21,154.8

Non-controlling interest



5.7

Total Equity


21,537.1


21,160.5

Total Liabilities and Equity


$

63,970.3


$

54,277.8

 

 

CME Group Inc. and Subsidiaries

Consolidated Statements of Income

(dollars in millions, except per share amounts; shares in thousands)




Quarter Ended
September 30,


Nine Months Ended
September 30,



2014


2013


2014


2013

Revenues









Clearing and transaction fees


$

641.8


$

597.9


$

1,903.3


$

1,883.6

Market data and information services


87.7


78.6


266.7


238.9

Access and communication fees


20.8


20.3


61.6


62.4

Other


12.1


17.8


39.8


64.4

Total Revenues


762.4


714.6


2,271.4


2,249.3

Expenses









Compensation and benefits


132.1


134.0


407.3


392.3

Communications


7.8


9.2


24.3


26.7

Technology support services


13.8


13.4


42.3


39.6

Professional fees and outside services


32.2


35.6


99.3


85.4

Amortization of purchased intangibles


25.3


25.6


75.7


77.4

Depreciation and amortization


32.7


35.0


101.1


100.8

Occupancy and building operations


24.7


19.2


71.1


56.7

Licensing and other fee agreements


25.5


25.7


80.2


73.8

Other


37.9


16.4


73.2


82.8

Total Expenses


332.0


314.1


974.5


935.5

Operating Income


430.4


400.5


1,296.9


1,313.8

Non-Operating Income (Expense)









Investment income


7.4


12.6


25.7


34.9

Interest and other borrowing costs


(28.7)


(34.6)


(90.7)


(112.8)

Equity in net gains (losses) of unconsolidated subsidiaries


20.0


20.4


63.9


58.1

Other non-operating income (expense)




1.8


Total Non-Operating


(1.3)


(1.6)


0.7


(19.8)

Income before Income Taxes


429.1


398.9


1,297.6


1,294.0

Income tax provision


139.1


162.6


477.2


509.0

Net Income


290.0


236.3


820.4


785.0

Less: net income (loss) attributable to non-controlling interests



(0.4)


(0.2)


1.3

Net Income Attributable to CME Group


$

290.0


$

236.7


$

820.6


$

783.7

Earnings per Common Share Attributable to CME Group:









Basic


$

0.87


$

0.71


$

2.46


$

2.36

Diluted


0.86


0.71


2.44


2.35

Weighted Average Number of Common Shares:









Basic


334,424


332,763


334,144


332,355

Diluted


336,172


334,674


335,820


334,055

 

 

CME Group Inc. and Subsidiaries

Quarterly Operating Statistics




3Q 2013


4Q 2013


1Q 2014


2Q 2014


3Q 2014

Trading Days


64


64


61


63


64














Quarterly Average Daily Volume (ADV)

CME Group ADV (in thousands)


Product Line


3Q 2013


4Q 2013


1Q 2014


2Q 2014


3Q 2014

Interest rate


5,839


5,274


6,725


6,668


7,181

Equity


2,408


2,471


2,890


2,465


2,586

Foreign exchange


792


705


817


638


797

Energy


1,609


1,571


1,705


1,457


1,562

Agricultural commodity


1,009


992


1,168


1,084


1,058

Metal


360


317


355


323


308

Total


12,018


11,331


13,659


12,636


13,493

Venue











Electronic


10,199


9,723


11,703


10,888


11,627

Open outcry


1,173


957


1,179


1,100


1,208

Privately negotiated*


646


651


778


647


657

Total


12,018


11,331


13,659


12,636


13,493



Average Rate Per Contract (RPC)

CME Group RPC


Product Line


3Q 2013


4Q 2013


1Q 2014


2Q 2014


3Q 2014

Interest rate


$

0.484


$

0.504


$

0.481


$

0.473


$

0.473

Equity


0.695


0.702


0.712


0.714


0.687

Foreign exchange


0.819


0.835


0.804


0.861


0.788

Energy


1.300


1.279


1.364


1.298


1.291

Agricultural commodity


1.323


1.327


1.369


1.430


1.362

Metal


1.626


1.682


1.707


1.715


1.707

Average RPC


$

0.762


$

0.780


$

0.767


$

0.749


$

0.725


*The privately negotiated venue average daily volume includes both traditional block trades as well as what was historically categorized as CME ClearPort. Going forward there will no longer be a break out for CME ClearPort.

 

 

CME Group Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Measures

(dollars in millions, except per share amounts; shares in thousands)






Quarter Ended



September 30, 2014

GAAP Net Income Attributable to CME Group


$

290.0




Foreign exchange transaction losses1


12.8




Acquisition-related costs


2.7




Income tax effect related to above


(5.8)




Other income tax items2


(18.9)




Adjusted Net Income Attributable to CME Group


$

280.8




GAAP Earnings per Common Share Attributable to CME Group:



     Basic


$

0.87

     Diluted


0.86




Adjusted earnings per Common Share Attributable to CME Group:



     Basic


$

0.84

     Diluted


0.84




Weighted Average Number of Common Shares:



     Basic


334,424

     Diluted


336,172


1.  Third-quarter 2014 results included foreign exchange transaction net losses principally related to cash held in British pounds within foreign entities whose functional currency is the U.S. dollar.


2. Other income tax items include the impact of a change in state and local tax apportionment factors and a favorable settlement of various tax audits.


SOURCE CME Group Inc.